We get a lot of questions about Peptide Receptor Radionuclide Therapy (PRRT). This is a list of questions answered by Dawn Marie about her personal experience with PRRT. What to take with? Some say hardly anything because of the radioactive. They kept me hospitalized in Europe for several days because of the radiation levels. Here in the U.S., I understand that they send you home the same day. So, I
In August, I went to see my specialist in Iowa City and was presented with terrible news. The lesions in my liver went to 5% tumor burden in January 2017 to 30% tumor burden in August 2017. PRRT was completely ineffective for me. (Or maybe it was effective and the results could have been worse.) But, my tumor activity was never this active prior to treatment. Doctor O’Dorisio told me
Advanced Accelerator Applications S.A. (AAA) has announced that the Food and Drug Administration (FDA), in the United States, has accepted and considered complete the resubmission of the New Drug Application (NDA) for its investigational drug lutetium Lu 177 dotatate (Lutathera). Lutathera is the brand name for the radiologic used in Peptide Receptor Radionuclide Therapy (PRRT). The FDA has set an action date of Jan 26, 2018. AAA is attempting to obtain U.S.
You must be logged in to post a comment.